FeesSafety
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Marqeta Inc (MQ) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

NVIDIA Board launches probe into CEO Jensen Huang over foreign intelligence concerns.

NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...

Market News
1 hour ago
Na
Neutral
NVIDIA Board launches probe into CEO Jensen Huang over foreign intelligence concerns.

Nvidia CEO under board investigation after admitting infidelity, sparking stock drop and investor concerns.

Nvidia's board has launched an independent investigation into CEO Jensen Huang following his admission of infidelity and reports linking him to a foreign intelligence probe. Despite the investigation, the board expressed confidence in Huang and state...

Market News
5 hours ago
24/7 Wall Street
Bearish
news icon
Nvidia CEO under board investigation after admitting infidelity, sparking stock drop and investor concerns.

Bitcoin miner stocks surge 13% as miners pivot to AI leases despite Bitcoin price drop below $75,000

Shares of Bitcoin miners Bitdeer and Riot jumped 13% even as Bitcoin fell below $75,000, its lowest since August. The rally is driven by these miners shifting their business model from relying on Bitcoin price to securing long-term AI data center lea...

Market News
5 hours ago
24/7 Wall Street
Bullish
news icon
Bitcoin miner stocks surge 13% as miners pivot to AI leases despite Bitcoin price drop below $75,000

Nvidia probes CEO Jensen Huang over alleged foreign spy link; Huang stays as CEO during investigation.

Nvidia's board is investigating whether CEO Jensen Huang was involved in a foreign intelligence scheme. Despite the probe, Huang will remain in his role without interruption and will cooperate with the investigation. The company emphasized that this ...

Market News
5 hours ago
Market Watch
Neutral
Nvidia probes CEO Jensen Huang over alleged foreign spy link; Huang stays as CEO during investigation.

Michael Burry bets Fiserv could fetch $100-$120 a share if bought, despite current stock at $62.88.

Investor Michael Burry suggests Fiserv's stock could reach $100 to $120 per share if a buyer emerges, valuing the company at $53-$64 billion plus $27 billion debt. The stock recently rose to $62.88 after a 42% rebound from a low of $44.36, but no acq...

Market News
5 hours ago
24/7 Wall Street
Bullish
news icon
Michael Burry bets Fiserv could fetch $100-$120 a share if bought, despite current stock at $62.88.

Nvidia launches probe after CEO Jensen Huang linked to Chinese spy allegations.

Nvidia's board announced an independent investigation after reports surfaced that CEO Jensen Huang was targeted by a Chinese spy operation through an affair with Alice Huang, a former chip executive allegedly recruited by Chinese intelligence. Jensen...

Market News
5 hours ago
TechCrunch
Bearish
news icon
Nvidia launches probe after CEO Jensen Huang linked to Chinese spy allegations.

South Korean stocks plunge over 8% on Friday amid tech turmoil and AI regulation fears

South Korea's Kospi index dropped more than 8% on Friday, reflecting global tech sector instability and concerns about stricter AI regulations under Democratic governments. This sharp decline signals heightened market volatility and investor caution,...

Market News
6 hours ago
Barrons
Bearish
news icon
South Korean stocks plunge over 8% on Friday amid tech turmoil and AI regulation fears

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Market News
6 hours ago
Crispr Therapeutics
Bullish
news icon
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

Market News
6 hours ago
Cullinan Therapeutics, Inc.
Bullish
news icon
Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

AVITA Medical to host investor webinar on Nov 11 covering Q3 2026 results and business update

AVITA Medical announced an investor webinar on November 11, 2026, where CEO Cary Vance and CFO David O’Toole will discuss the company's third-quarter 2026 financial and business results. The session will include a Q&A segment for participants who can...

Market News
6 hours ago
GlobeNewsWire
Neutral
AVITA Medical to host investor webinar on Nov 11 covering Q3 2026 results and business update
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $1.93B
  • Volume
    647,608
  • Sector
    Technology
  • 52W High
    $20.32
  • 52W Low
    $15.04
  • Typical Hold Time
    44 Days
  • Enterprise Value
    $1.25B
  • Div Yield
    -
  • Trading Activity
    -
$18.59
52W Low: $15.04
22 Jun 2026
52W High: $20.32
22 Dec 2025

Track Marqeta Inc (MQ) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Marqeta Inc has traded between a low of $15.04 and a high of $20.32, highlighting its annual price range. Buy and sell Marqeta Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!